We are live on ! Find out more
SG

StoneX Group Portfolio holdings

AUM $1.86B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
-4.71%
1 Year Est. Return
+21.3%
3 Year Est. Return
+67.54%
5 Year Est. Return
+78.7%
10 Year Est. Return
AUM
$537M
AUM Growth
-$73.6M
Cap. Flow
-$47M
Cap. Flow %
-8.75%
Top 10 Hldgs %
41.68%
Holding
594
New
80
Increased
99
Reduced
167
Closed
232

Sector Composition

Rank Sector Weight
1 Energy 0.95%
2 Financials 0.93%
3 Industrials 0.13%
4 Consumer Discretionary 0.09%
5 Technology 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTB
301
RTB Digital
RTB
$212M
$10.9K ﹤0.01%
32
-3
-9% -$1.08K
MTNB icon
302
Matinas BioPharma
MTNB
$1.55M
$8.84K ﹤0.01%
+278
New +$10.9K
SFT
303
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$8.43K ﹤0.01%
1,204
-296
-20% -$2.84K
APRE icon
304
Aprea Therapeutics
APRE
$7.83M
$8.14K ﹤0.01%
626
-109
-15% -$1.93K
CFIVW
305
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$7.67K ﹤0.01%
+153,420
New +$11.9K
FABC
306
Fabric.AI Inc
FABC
$16.8M
$6.8K ﹤0.01%
90
-2
-2% -$229
KUST
307
Kustom Entertainment Inc
KUST
$846K
0
VISL
308
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$6.32K ﹤0.01%
745
-5
-0.7% -$56
SMTS
309
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$6.03K ﹤0.01%
+12,186
New +$7K
SOGP
310
Sound Group
SOGP
$45.9M
$5.92K ﹤0.01%
+1,005
New +$10.5K
ASPU
311
DELISTED
ASPEN GROUP, INC.
ASPU
$5.61K ﹤0.01%
14,692
-308
-2% -$267
IMCC
312
IM Cannabis
IMCC
$1.09M
$5.58K ﹤0.01%
227
-23
-9% -$712
MBSC.WS
313
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$5.12K ﹤0.01%
+106,609
New +$12.3K
ADIL
314
Adial Pharmaceuticals
ADIL
$6.08M
$4.83K ﹤0.01%
22
-2
-8% -$902
CEMI
315
DELISTED
Chembio diagnostics, Inc.
CEMI
$4.79K ﹤0.01%
13,269
-3,166
-19% -$2.16K
RKTO
316
Rocket One Inc
RKTO
$17.7M
$4.72K ﹤0.01%
543
-57
-10% -$590
RETO icon
317
ReTo Eco-Solutions
RETO
$23.2M
0
KRBP
318
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$4.35K ﹤0.01%
+500
New +$5.8K
EQOS
319
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$4.35K ﹤0.01%
+10,865
New +$7.13K
GROM
320
DELISTED
Grom Social Enterprises Inc. Common Stock
GROM
$4.17K ﹤0.01%
+21
New +$5K
OTMO
321
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$3.98K ﹤0.01%
+940
New +$8.51K
RKLY.WS
322
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$3.81K ﹤0.01%
+38,076
New +$8.17K
OTIC
323
DELISTED
Otonomy, Inc.
OTIC
$3.75K ﹤0.01%
+12,723
New +$11.2K
DSS icon
324
DSS Inc
DSS
$5.52M
$3.73K ﹤0.01%
785
+246
+46% +$1.58K
AMST icon
325
Amesite
AMST
$5.79M
$3.62K ﹤0.01%
1,250
-9
-0.7% -$49

Similar funds

StoneX Group's Q3 2022 Portfolio in Review

As of Q3 2022, StoneX Group held 594 positions worth $537M, down 12% from $611M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

StoneX Group withdrew a net $47M in Q3 2022, closing 232 positions and reducing 167 holdings. Its most notable exit was Phillips 66, an estimated $6.64M position sold in full.

By sector, the portfolio is most concentrated in Energy at 0.95% of assets, down from 1.2% a quarter earlier, followed by Financials and Industrials.

Against the trend, StoneX Group opened a new position in Occidental Petroleum worth $5.11M.

  • StoneX Group's largest Q3 2022 buy was Occidental Petroleum: 83,207 shares worth $5.11M.
  • StoneX Group added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $6.13M increase.
  • StoneX Group's biggest Q3 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $14.6M.
  • StoneX Group fully exited Phillips 66 in Q3 2022, selling an estimated $6.64M.
  • StoneX Group's ten largest holdings make up 42% of its $537M portfolio in Q3 2022.
  • StoneX Group opened 80 new positions and closed 232 in Q3 2022.
  • StoneX Group's portfolio value fell 12% quarter-over-quarter to $537M.

Based on StoneX Group's 13F filing for Q3 2022, filed 8 Nov 2022.